nach oben

Erschienen in:

23.02.2022 | COVID-19 | Dementia (J Pillai, Section Editor) Zur Zeit gratis

Dementia Clinical Care in Relation to COVID-19

verfasst von: Angelo Bianchetti, MD, Renzo Rozzini, MD, Luca Bianchetti, MD, Flaminia Coccia, MD, Fabio Guerini, MD, Marco Trabucchi, MD

Erschienen in: Current Treatment Options in Neurology | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

This review discusses the complex relationship between COVID-19 and dementia and how the pandemic has affected the management of patients with dementia. This population resulted particularly susceptible to SARS-CoV-2 infection and its effects and also to the negative effects of the measures taken worldwide to control the spread of the virus.

Recent Findings

Patients with dementia were at increased risk for COVID-19 compared to patients without dementia, and diagnosis of dementia represents an independent risk factor for hospitalization in COVID-19 patients. Mortality due to SARS-CoV2 infection in subjects with dementia is 2–5 times higher than in the general population. Cognitive impairment and delirium have been described in COVID-19 survivors. SARS-COV2 pandemic exacerbates the vulnerability of dementia patients and their caregivers, due to the morbidity and mortality from COVID-19, the indirect effects of the pandemic on the social supports, and the effects on healthcare system on which they depend.

Summary

The COVID-19 pandemic requires people with dementia to move from traditional models of health care to innovative models for home care, to support caregivers’ burden, and to improve long term care.

Skegg D, Gluckman P, Boulton G, Hackmann H, Karim SSA, Piot P, Woopen C. Future scenarios for the COVID-19 pandemic. Lancet. 2021;397:777–778. https://doi.org/10.1016/S0140-6736(21)00424-4.

•• Dumitrascu F, Branje KE, Hladkowicz ES, Lalu M, McIsaac DI. Association of frailty with outcomes in individuals with COVID-19: a living review and meta-analysis. J Am Geriatr Soc. 2021;1–11. https://doi.org/10.1111/jgs.17299. An important review about the association of frailty and the mortality risk in COVID-19 patients.

Brown EE, Kumar S, Rajji TK, Pollock BG, Mulsant BH. Anticipating and mitigating the impact of the COVID-19 pandemic on Alzheimer’s disease and related dementias. Am J Geriatr Psychiatry. 2020;7:712–721. https://doi.org/10.1016/j.jagp.2020.04.010.

Zhou Y, Xu J, Hou Y, Leverenz JB, Kallianpur A, Mehra R, Liu Y, Yu H, Pieper AA, Jehi L, Cheng F. Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment. Alzheimers Res Ther. 2021;13:1102021. https://doi.org/10.1101/2021.03.15.435423.

Wang H, Li T, Barbarino P, Gauthier S, Brodaty H, Molinuevo JL, Xie H, Sun Y, Yu E, Tang Y, Weidner W, Yu X. Dementia care during COVID-19. Lancet. 2020;395:1190–1191. https://doi.org/10.1016/S0140-6736(20)30755-8.

Marengoni A, Zucchelli A, Vetrano DL, Armellini A, Botteri E, Nicosia F, Romanelli G, Beindorf EA, Giansiracusa P, Garrafa E, Ferrucci L, Fratiglioni L, Bernabei R, Onder G. Beyond chronological age: frailty and multimorbidity predict in-hospital mortality in patients with coronavirus disease 2019. J Gerontol A Biol Sci Med Sci. 2021;76:e38–e45. https://doi.org/10.1093/gerona/glaa291.

Emmerton D, Khan S, Conway J, Mosby D, Abdelhafiz AH. Ageing, comorbidity and frailty-synergistic risk factors for covid-19 adverse outcomes. OBM Geriatrics. 2020;4. https://doi.org/10.21926/obm.geriatr.2003127.

Liu N, Sun J, Wang X, Zhao M, Huang Q, Li H. The impact of dementia on the clinical outcome of COVID-19: a systematic review and meta-analysis. J Alzheimers Dis. 2020;78:1775–1782.

Atkins JL, Masoli JAH, Delgado J, Pilling LC, Kuo CL, Kuchel GA, Melzer D. Preexisting comorbidities predicting COVID-19 and mortality in the UK Biobank Community Cohort. J Gerontol A Biol Sci Med Sci. 2020;75:2224–2230. https://doi.org/10.1093/gerona/glaa183.

10.

Azarpazhooh MR, Amiri A, Morovatdar N, Steinwender S, Rezaei Ardani A, Yassi N, Biller J, Stranges S, Tokazebani Belasi M, Neya SK, Khorram B, Sheikh Andalibi MS, Arsang-Jang S, Mokhber N, Di Napoli M. Correlations between COVID-19 and burden of dementia: an ecological study and review of literature. J Neurol Sci. 2020;416:117013. https://doi.org/10.1016/j.jns.2020.117013.

11.

Bianchetti A, Rozzini R, Guerini F, Boffelli S, Ranieri P, Minelli G, Bianchetti L, Trabucchi M. Clinical presentation of COVID19 in dementia patients. J Nutr Health Aging. 2020;24:560–562. https://doi.org/10.1007/s12603-020-1389-1.

12.

Zuin M, Guasti P, Roncon L, Cervellati C, Zuliani G. Dementia and the risk of death in elderly patients with COVID‐19 infection: systematic review and meta‐analysis. Int J Ger Psych. 2021;36:697–703. https://doi.org/10.1002/gps.5468.

13.

Wan Y,Wu J, Ni L, Luo Q, Yuan C, Fan F, Liu H, Zhang C, Xiang Y, Xie Q. Prognosis analysis of patients with mental disorders with COVID-19: a single-center retrospective study. Aging. 2020;12:11238–11244.

14.

Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C, et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med. 2020;382:2268–2270. https://doi.org/10.1056/NEJMc2008597.

15.

Jaywant A, Vanderlind WM, Alexopoulos GS, Fridman CB, Perlis RH, Gunning FM. Frequency and profile of objective cognitive deficits in hospitalized patients recovering from COVID-19. Neuropsychopharmacology. 2021;1–6. https://doi.org/10.1038/s41386-021-00978-8.

16.

Raman B, Cassar MP, Tunnicliffe EM, Filippini N, Griffanti L, Alfaro-Almagro F, Okell T, Sheerin F, Xie C, Mahmod M, Mózes FE, Lewandowski AJ, Ohuma EO, Holdsworth D, Lamlum H, Woodman MJ, Krasopoulos C, Mills R, McConnell FAK, Wang C, Arthofer C, Lange FJ, Andersson J, Jenkinson M, Antoniades C, Channon KM, Shanmuganathan M, Ferreira VM, Piechnik SK, Klenerman P, Brightling C, Talbot NP, Petousi N, Rahman NM, Ho LP, Saunders K, Geddes JR, Harrison PJ, Pattinson K, Rowland MJ, Angus BJ, Gleeson F, Pavlides M, Koychev I, Miller KL, Mackay C, Jezzard P, Smith SM, Neubauer S. Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine. 2021;31:100683. https://doi.org/10.1016/j.eclinm.2020.100683.

17.

Foroughi M, Gupta R, Ganguly A, Mirza J, Fotros A. Neuropsychiatric manifestations of COVID-19: a review. Advances in Psychiatry and Behavioral Health. 2021;1:161–172. https://doi.org/10.1016/j.ypsc.2021.05.003.

18.

•• Toniolo S, Scarioni M, Di Lorenzo F, Hort J, Georges J, Tomic S, Nobili F, Frederiksen KS; Management group of the EAN dementia and cognitive disorders scientific panel. Dementia and COVID-19, a bidirectional liaison: risk factors, biomarkers, and optimal health care. J Alzheimer’s Dis. 2021. https://doi.org/10.3233/JAD-210335. Epub ahead of print. PMID: 34092646. An article that explores the bidirectional relationship between SARS-CoV-2 infection and cognitive impairment.

19.

Rahman MA, Islam K, Rahman S, Alamin M. Neurobiochemical cross-talk between COVID-19 and Alzheimer’s disease. Mol Neurobiol. 202;58:1017-1023. https://doi.org/10.1007/s12035-020-02177.

20.

Gkouskou K, Vasilogiannakopoulou T, Andreakos E, Davanos N, Gazouli M, Sanoudou D, Eliopoulos AG. COVID-19 enters the expanding network of apolipoprotein E4-related pathologies. Redox Biol. 2021;41:101938. https://doi.org/10.1016/j.redox.2021.101938.

21.

Xiong N, Schiller MR, Li J, Chen X, Lin Z. Severe COVID-19 in Alzheimer’s disease: APOE4’s fault again? Alzheimers Res Ther. 2021;13:111. https://doi.org/10.1186/s13195-021-00858-9.

22.

• De Leo D, Trabucchi M. The fight against COVID-19: a report from the Italian trenches. Int Psychogeriatr. 2020;32:1161-1164. https://doi.org/10.1017/S1041610220000630. The article analyzes the complex socio-health situation created as a result of the pandemic in the elderly population, with particular reference to Italy.

23.

Brooks SK, Webster RK, Smith LE, Woodland L, Wessely S, Greenberg N, Rubin GJ. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. 2020;395:912–920. https://doi.org/10.1016/S0140-6736(20)30460-8.

24.

Caratozzolo S, Zucchelli A, Turla M, Cotelli MS, Fascendini S, Zanni M, Bianchetti A, Psy MP, Rozzini R, Boffelli S, Cappuccio M, Psy FG, Psy CV, Bellandi D, Caminati C, Gentile S, Psy EL, Di Fazio I, Psy MZ, Vezzadini G, Psy CF, Psy MC, Psy RT, Psy SP, Scalvini A, Di Cesare M, Psy MG, Falanga L, Medici N, Palamini N, Psy EZ, Psy EG, Bellelli G, Marengoni A, Trabucchi M, Padovani A. COVIDEM Network. The impact of COVID-19 on health status of home-dwelling elderly patients with dementia in East Lombardy, Italy: results from COVIDEM network. Aging Clin Exp Res. 2020;32:2133–2140. https://doi.org/10.1007/s40520-020-01676-z.

25.

Shea YF, Wan WH, Chan MMK, DeKosky ST. Time-to-change: dementia care in COVID-19. Psychogeriatrics. 2020;20:792–793. https://doi.org/10.1111/psyg.12576.

26.

Cagnin A, Di Lorenzo R, Marra C, Bonanni L, Cupidi C, Laganà V, Rubino E, Vacca A, Provero P, Isella V, Vanacore N, Agosta F, Appollonio I, Caffarra P, Pettenuzzo I, Sambati R, Quaranta D, Guglielmi V, Logroscino G, Filippi M, Tedeschi G, Ferrarese C, Rainero I, Bruni AC. SINdem COVID-19 study group. Behavioral and psychological effects of coronavirus disease-19 quarantine in patients with dementia. Front Psychiatry. 2020;11:578015. https://doi.org/10.3389/fpsyt.2020.578015.

27.

Capozzo R, Zoccolella S, Frisullo ME, Barone R, Dell'Abate MT, Barulli MR, Musio M, Accogli M, Logroscino G. Telemedicine for delivery of care in frontotemporal lobar degeneration during COVID-19 pandemic: results from Southern Italy. J Alzheimers Dis. 2020;76:481–489. https://doi.org/10.3233/JAD-200589.

28.

Wang Q, Davis PB, Gurney ME, Xu R. COVID-19 and dementia: analyses of risk, disparity, and outcomes from electronic health records in the US. Alzheimers Dement. 2021;17:1297–1306. https://doi.org/10.1002/alz.12296.

29.

Hariyanto TI, Putri C, Arisa J, Situmeang RFV, Kurniawan A. Dementia and outcomes from coronavirus disease 2019 (COVID-19) pneumonia: a systematic review and meta-analysis. Arch Gerontol Geriatr. 2020;93:104299. https://doi.org/10.1016/j.archger.2020.104299.

30.

Trabucchi M, De Leo D. Nursing homes or besieged castles: COVID-19 in northern Italy. Lancet Psychiatry. 2020;7:387–388.

31.

De Girolamo G, Bellelli G, Bianchetti A, Starace F, Zanetti O, Zarbo C, Micciolo R. Older people living in long-term care facilities and mortality rates during the COVID-19 pandemic in Italy: preliminary epidemiological data and lessons to learn. Front Psychiatry. 2020;11:586524. https://doi.org/10.3389/fpsyt.2020.586524.

32.

Thompson DC, Barbu MG, Beiu C, Popa LG, Mihai MM, Berteanu M, Popescu MN. The impact of COVID-19 pandemic on long-term care facilities worldwide: an overview on international issues. Biomed Res Int. 2020:8870249. https://doi.org/10.1155/2020/8870249.

33.

Rozzini R, Bianchetti A, Mazzeo F, Cesaroni G, Bianchetti L, Trabucchi M. Delirium: clinical presentation and outcomes in older COVID-19 patients. Front Psychiatry. 2020;11:586686. https://doi.org/10.3389/fpsyt.2020.586686.

34.

De Smet R, Mellaerts B, Vandewinckele H, Lybeert P, Frans E, Ombelet S, Lemahieu W, Symons R, Ho E, Frans J, Smismans A, Laurent MR. Frailty and mortality in hospitalized older adults with COVID-19: retrospective observational study. J Am Med Dir Assoc. 2020;21:928–932.e1. https://doi.org/10.1016/j.jamda.2020.06.008.

35.

Rebora P, Rozzini R, Bianchetti A, Blangiardo P, Marchegiani A, Piazzoli A, Mazzeo F, Cesaroni G, Chizzoli A, Guerini F, Bonfanti P, Morandi A, Faraci B, Gentile S, Bna C, Savelli G, Citerio G, Valsecchi MG, Mazzola P, Bellelli G. CoViD-19 Lombardia Team. Delirium in patients with SARS-CoV-2 infection: a multicenter study. J Am Geriatr Soc. 2021;69:293–299. https://doi.org/10.1111/jgs.16969.

36.

• Peterson A, Marengoni A, Shenkin S, MacLullich A. Delirium in COVID-19: Common, distressing and linked with poor outcomes… Can we do better? Age ageing. 2021;afab153. https://doi.org/10.1093/ageing/afab153. Epub ahead of print. PMID: 34174069. A review of observational studies assessing delirium prevalence, incidence and subsequent mortality.

37.

Jha NK, Ojha S, Jha SK, Dureja H, Singh SK, Shukla SD, Chellappan DK, Gupta G, Bhardwaj S, Kumar N, Jeyaraman M, Jain R, Muthu S, Kar R, Kumar D, Goswami VK, Ruokolainen J, Kesari KK, Singh SK, Dua K. Evidence of Coronavirus (CoV) Pathogenesis and emerging pathogen SARS-CoV-2 in the nervous system: a review on neurological impairments and manifestations. J Mol Neurosci. 2021;19:1–18. https://doi.org/10.1007/s12031-020-01767-6.

38.

Hawkins M, Sockalingam S, Bonato S, Rajaratnam T, Ravindran M, Gosse P, Sheehan KA. A rapid review of the pathoetiology, presentation, and management of delirium in adults with COVID-19. J Psychosom Res. 2021;141:110350. https://doi.org/10.1016/j.jpsychores.2020.110350.

39.

Bellelli G, Brathwaite JS, Mazzola P. Delirium: a marker of vulnerability in older people. Front Aging Neurosci. 2021;13:626127. https://doi.org/10.3389/fnagi.2021.626127.

40.

Pranata R, Huang I, Lim MA, Yonas E, Vania R, Kuswardhani RAT. Delirium and mortality in coronavirus disease 2019 (COVID-19) - a systematic review and meta-analysis. Arch Gerontol Geriatr. 2021;95:104388. https://doi.org/10.1016/j.archger.2021.104388.

41.

Stollings JL, Kotfis K, Chanques G, Pun BT, Pandharipande PP, Ely EW. Delirium in critical illness: clinical manifestations, outcomes, and management. Intensive Care Med. 202;16:1–15. https://doi.org/10.1007/s00134-021-06503-1.

42.

Meagher D, Adamis D, Timmons S, O’Regan NA, O’Keeffe S, Kennelly S, O’Sullivan R. Developing a guidance resource for managing delirium in patients with COVID-19. Irish Journal of Psychological Medicine. 2020;1–6. https://doi.org/10.1017/ipm.2020.71.

43.

Davis D, Searle SD, Tsui A. The Scottish intercollegiate guidelines network: risk reduction and management of delirium. Age Ageing. 2019;48:485–488. https://doi.org/10.1093/ageing/afz036.

44.

British Geriatrics Society, European Delirium Association and Old Age Psychiatry Faculty of the Royal College of Psychiatrists. Coronavirus: managing delirium in confirmed and suspected cases. 2020. https://www.bgs.org.uk/resources/coronavirus-managing-delirium-in-confirmed-and-suspected-cases.

45.

Di Giacomo E, Bellelli G, Peschi G, Scarpetta S, Colmegna F, de Girolamo G, Clerici M. Management of older people during the COVID‐19 outbreak: recommendations from an Italian experience. Int J Geriatr Psychiatry. 2020;35:803–805. https://doi.org/10.1002/gps.5318.

46.

Ostuzzi G, Gastaldon C, Papola D, Fagiolini A, Dursun S, Taylor D, Correll CU, Barbui C. Pharmacological treatment of hyperactive delirium in people with COVID-19: rethinking conventional approaches. Ther Adv Psychopharmacol. 2020;10:2045125320942703. https://doi.org/10.1177/2045125320942703.

47.

Li Y, Ma J, Jin Y, Li N, Zheng R, Mu W, Wang J, Si J, Chen J, Shang H. Benzodiazepines for treatment of patients with delirium excluding those who are cared for in an intensive care unit. Cochrane Database Syst Rev. 2020;2:CD012670. https://doi.org/10.1002/14651858.CD012670.pub2.

48.

Zambrelli E, Canevini M, Gambini O, D'Agostino A. Delirium and sleep disturbances in COVID-19: a possible role for melatonin in hospitalized patients? Sleep Med. 2020;70:111. https://doi.org/10.1016/j.sleep.2020.04.006.

49.

Xia X, Wang Y, Zheng J. COVID-19 and Alzheimer’s disease: how one crisis worsens the other. Transl Neurodegener. 2021;10:15. https://doi.org/10.1186/s40035-021-00237-2.

50.

Bianchetti A, Bellelli G, Guerini F, Marengoni A, Padovani A, Rozzini R, Trabucchi M. Improving the care of older patients during the COVID-19 pandemic. Aging Clin Exp Res. 2020;32:1883–1888. https://doi.org/10.1007/s40520-020-01641.

51.

Tousi B. Dementia Care in the Time of COVID-19 Pandemic. J Alzheimers Dis. 2020;76:475–479. https://doi.org/10.3233/JAD-200461. PMID: 32651326.

52.

Dellazizzo L, Léveillé, N, Landry C, Dumais A. Systematic Review on the Mental Health and Treatment Impacts of COVID-19 on Neurocognitive Disorders. J Pers Med 2021;11:746. https://doi.org/10.3390/jpm11080746.

53.

O'Caoimh R, O'Donovan MR, Monahan MP, Dalton O'Connor C, Buckley C, Kilty C, Fitzgerald S, Hartigan I, Cornally N. Psychosocial impact of COVID-19 nursing home restrictions on visitors of residents with cognitive impairment: a cross-sectional study as part of the engaging remotely in care (ERiC) project. Front Psychiatry. 2020;11:585373. https://doi.org/10.3389/fpsyt.2020.585373.

54.

Soiza RL, Scicluna C, Thomson EC. Efficacy and safety of COVID-19 vaccines in older people. Age Ageing. 2021;50:279–283. https://doi.org/10.1093/ageing/afaa274.

55.

Alzheimer Europe. COVID-19 vaccinations and people with dementia. Maj. 2021. https://www.alzheimer-europe.org/Policy/Our-opinion-on/2021-COVID-19-Vaccinations-and-People-with-Dementia.

56.

Gosse PJ, Kassardjian CD, Masellis M, Mitchell SB. Virtual care for patients with Alzheimer disease and related dementias during the COVID-19 era and beyond. CMAJ. 2021;193:E371–E377. https://doi.org/10.1503/cmaj.201938.

57.

Costanzo MC, Arcidiacono C, Rodolico A, Panebianco M, Aguglia E, Signorelli MS. Diagnostic and interventional implications of telemedicine in Alzheimer’s disease and mild cognitive impairment: a literature review. Int J Geriatr Psychiatry 2020;35:12–28. https://doi.org/10.1002/gps.5219.

58.

Hatcher-Martin JM, Adams JL, Anderson ER, Bove R, Burrus TM, Chehrenama M, O'Brien MD, Eliashiv DS, Erten-Lyons D, Giesser BS, Moo LR, Narayanaswami P, Rossi MA, Soni M, Tariq N, Tsao JW, Vargas BB, Vota SA, Wessels SR, Planalp H, Govindarajan R. Telemedicine in neurology: telemedicine work group of the American Academy of Neurology update. Neurology. 2020;94:30–38.

59.

Lai FH, Yan EW, Yu KK, Tsui WS, Chan DT, Yee BK. The protective impact of telemedicine on persons with dementia and their caregivers during the COVID-19 pandemic. Am J Geriatr Psychiatry. 2020;11:1175–1184. https://doi.org/10.1016/j.jagp.2020.07.019.

60.

Bhaskar S, Nurtazina A, Mittoo S, Banach M, Weissert R. Editorial: telemedicine during and beyond COVID-19. Front Public Health. 2021;16;9:662617. https://doi.org/10.3389/fpubh.2021.662617.

61.

Bhaskar S, Bradley S, Sakhamuri S, Moguilner S, Chattu VK, Pandya S, Schroeder S, Ray D, Banach M. Designing futuristic telemedicine using artificial intelligence and robotics in the COVID-19 era. Front Public Health. 2020;8:556789. https://doi.org/10.3389/fpubh.2020.556789.

62.

Zucca M, Isella V, Lorenzo RD, Marra C, Cagnin A, Cupidi C, Bonanni L, Laganà V, Rubino E, Vanacore N, Agosta F, Caffarra P, Sambati R, Quaranta D, Guglielmi V, Appollonio IM, Logroscino G, Filippi M, Tedeschi G, Ferrarese C, Rainero I, Bruni AC. SINdem COVID-19 Study Group. Being the family caregiver of a patient with dementia during the coronavirus disease 2019 lockdown. Front Aging Neurosci. 2021;13:653533. https://doi.org/10.3389/fnagi.2021.653533.

63.

Altieri M, Santangelo G. The psychological impact of COVID-19 pandemic and lockdown on caregivers of people with dementia. Am J Geriatr Psychiatry. 2021;1:27-–34. https://doi.org/10.1016/j.jagp.2020.10.009.

64.

Panagiotou OA, Kosar CM, White EM, Bantis LE, Yang X, Santostefano CM, Feifer RA, Blackman C, Rudolph JL, Gravenstein S, Mor V. Risk factors associated with all-cause 30-day mortality in nursing home residents with COVID-19. JAMA Intern Med. 2021;181:439–448. https://doi.org/10.1001/jamainternmed.2020.7968.

65.

Comas-Herrera A, Zalakaín J, Lemmon E, Henderson D, Litwin C, Hsu AT, Schmidt AE, Arling G, Kruse F and Fernández J-L. Mortality associated with COVID-19 in care homes: international evidence. Article in LTCcovid.org, International Long-Term Care Policy Network, CPEC-LSE. 1st Feb 2021. 2020.

66.

Lombardo FL, Salvi E, Lacorte E, Piscopo P, Mayer F, Ancidoni A, Remoli G, Bellomo G, Losito G, D'Ancona F, Canevelli M, Onder G, Vanacore N. Italian National Institute of Health Nursing Home Study Group. Adverse events in Italian nursing homes during the COVID-19 epidemic: a national survey. Front Psychiatry. 2020;11:578465. https://doi.org/10.3389/fpsyt.2020.578465.

67.

Mor V, Gutman R, Yang X, White EM, McConeghy KW, Feifer RA, Blackman CR, Kosar CM, Bardenheier BH, Gravenstein SA. Short-term impact of nursing home SARS-CoV-2 vaccinations on new infections, hospitalizations, and deaths. J Am Geriatr Soc. 2021;69:2063–2069. https://doi.org/10.1111/jgs.17176.

68.

Teran RA, Walblay KA, Shane EL, Xydis S, Gretsch S, Gagner A, Samala U, Choi H, Zelinski C, Black SR. Postvaccination SARS-CoV-2 infections among skilled nursing facility residents and staff members — Chicago, Illinois, Dec 2020–Marh 2021. MMWR Morb Mortal Wkly Rep. 2021;70:632–638. https://doi.org/10.15585/mmwr.mm7017e1.

69.

CDC. COVID-19 Nursing Home Data. 2021. https://data.cms.gov/covid-19/covid-19-nursing-home-data.

70.

Martone AM, Ciciarello F, Landi F. For the Gemelli Against COVID-19 Geriatric Team. Treatment of COVID-19 disease in older people with cognitive impairment: a challenge into the challenge. JGG. 2020;68:224–230. https://doi.org/10.36150/2499-6564-271.

71.

Chase J. Caring for frail older adults during COVID-19: integrating public health ethics into clinical practice. J Am Geriatr Soc. 2020;68:1666–1670. https://doi.org/10.1111/jgs.16666.

Titel: Dementia Clinical Care in Relation to COVID-19
verfasst von: Angelo Bianchetti, MD
Renzo Rozzini, MD
Luca Bianchetti, MD
Flaminia Coccia, MD
Fabio Guerini, MD
Marco Trabucchi, MD
Publikationsdatum: 23.02.2022
Verlag: Springer US
Schlagwort: COVID-19
Erschienen in: Current Treatment Options in Neurology / Ausgabe 1/2022
Print ISSN: 1092-8480
Elektronische ISSN: 1534-3138
DOI: https://doi.org/10.1007/s11940-022-00706-7

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Demenzkranke durch Antipsychotika vielfach gefährdet

Demenz Nachrichten

Der Einsatz von Antipsychotika gegen psychische und Verhaltenssymptome in Zusammenhang mit Demenzerkrankungen erfordert eine sorgfältige Nutzen-Risiken-Abwägung. Neuen Erkenntnissen zufolge sind auf der Risikoseite weitere schwerwiegende Ereignisse zu berücksichtigen.

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen